Varkaris, A., Pazolli, E., Gunaydin, H., Wang, Q., Pierce, L., Boezio, A. A., Bulku, A., DiPietro, L., Fridrich, C., Frost, A., Giordanetto, F., Hamilton, E. P., Harris, K., Holliday, M., Hunter, T. L., Iskandar, A., Ji, Y., Larivée, A., LaRochelle, J. R., … Kipp, D. R. (2023). Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discovery, 14(2), 240–257. https://doi.org/10.1158/2159-8290.cd-23-0944

Reyes Diaz, J. V., Jin, Y., Garber, K., Cossen, K. M., Li, Y., Jin, P., Li, H., & Ham, J. N. (2022). A homozygous exonic variant leading to exon skipping in ABCC8 as the cause of severe congenital hyperinsulinism. American Journal of Medical Genetics Part A, 188(8), 2429–2433. Portico. https://doi.org/10.1002/ajmg.a.62843